FOXO Technologies raises $10 million
Following our February’s coverage of FOXO Technologies , the Minneapolis-based company is now announcing a $10 million investment round led by healthcare and technology investor Bespoke Growth Partners. The investment represents the first external capital FOXO has received and brings its total funding to $40 million.
Founded in 2016, FOXO develops and commercializes epigenetic biomarkers of health and aging. This funding round will support FOXO’s purchase of Memorial Life Insurance Company of America, which upon regulatory approval and closing, will be renamed FOXO Life.